CLARKE JOHN K

CIK 00012190157 companiesCAMBRIDGE, MA

SEC Profile

Transactions

Companies

Filings

CIK

0001219015

Recent Transactions

50 trades

Award
aTYR PHARMA INC$ATYR
Stock Option (right to buy)
2024-05-22+24,000→ 24,000 total
Award
aTYR PHARMA INC$ATYR
Stock Option (right to buy)
2023-05-17+12,000→ 12,000 total
Exercise/Conversion
aTYR PHARMA INC$ATYR
Restricted Stock Unit
2023-04-26−6,000→ 0 total
Exercise/Conversion
aTYR PHARMA INC$ATYR
Common Stock
2023-04-26+6,000→ 19,797 total
Award
aTYR PHARMA INC$ATYR
Restricted Stock Units
2022-04-26+6,000→ 6,000 total
Sale
aTYR PHARMA INC$ATYR
Common Stock
2021-05-21$4.34/sh−2,500→ 108,083 total
Award
aTYR PHARMA INC$ATYR
Stock Option (right to buy)
2021-04-28+1,428→ 1,428 total
Sale
aTYR PHARMA INC$ATYR
Common Stock
2020-09-02$4.01/sh−7,260→ 110,583 total
Sale
aTYR PHARMA INC$ATYR
Common Stock
2020-08-28$4.00/sh−100→ 117,843 total
Sale
aTYR PHARMA INC$ATYR
Common Stock
2020-08-27$4.09/sh−5,440→ 117,943 total
Sale
aTYR PHARMA INC$ATYR
Common Stock
2020-08-26$4.30/sh−2,200→ 123,383 total
Award
aTYR PHARMA INC$ATYR
Stock Option (right to buy)
2020-05-06+1,428→ 1,428 total
Award
aTYR PHARMA INC$ATYR
Stock Option (right to buy)
2019-05-08+20,000→ 20,000 total
Award
ALNYLAM PHARMACEUTICALS, INC.$ALNY
Stock Option (right to buy)
2018-06-20+9,000→ 9,000 total
Sale
ALNYLAM PHARMACEUTICALS, INC.$ALNY
Common Stock
2018-05-31$101.37/sh−2,100→ 8,991 total
Exercise/Conversion
ALNYLAM PHARMACEUTICALS, INC.$ALNY
Stock Option (right to buy)
2018-05-31−15,000→ 0 total
Sale
ALNYLAM PHARMACEUTICALS, INC.$ALNY
Common Stock
2018-05-31$100.33/sh−10,042→ 11,091 total
Sale
ALNYLAM PHARMACEUTICALS, INC.$ALNY
Common Stock
2018-05-31$101.97/sh−100→ 8,891 total
Exercise/Conversion
ALNYLAM PHARMACEUTICALS, INC.$ALNY
Common Stock
2018-05-31$27.28/sh+15,000→ 23,891 total
Sale
ALNYLAM PHARMACEUTICALS, INC.$ALNY
Common Stock
2018-05-31$99.38/sh−2,758→ 21,133 total
Award
aTYR PHARMA INC$ATYR
Stock Option (right to buy)
2018-05-15+20,000→ 20,000 total
Award
ALNYLAM PHARMACEUTICALS, INC.$ALNY
Stock Option (right to buy)
2017-06-02+11,250→ 11,250 total
Award
aTYR PHARMA INC$ATYR
Stock Option (right to buy)
2017-05-09+20,000→ 20,000 total
Award
ALNYLAM PHARMACEUTICALS, INC.$ALNY
Stock Option (right to buy)
2016-06-03+11,250→ 11,250 total
Award
aTYR PHARMA INC$ATYR
Stock Option (right to buy)
2016-05-24+18,000→ 18,000 total
Award
aTYR PHARMA INC$ATYR
Stock Option (right to buy)
2016-01-27+19,428→ 19,428 total
Award
aTYR PHARMA INC$ATYR
Stock Option (right to buy)
2015-07-08+6,286→ 6,286 total
Award
MOMENTA PHARMACEUTICALS INC
Stock Option (Right to Buy)
2015-06-10+17,750→ 176,350 total
Award
ALNYLAM PHARMACEUTICALS, INC.$ALNY
Stock Option (right to buy)
2015-06-01+11,250→ 11,250 total
Conversion
aTYR PHARMA INC$ATYR
Series B-2 Redeemable Convertible Preferred Stock
2015-05-12−4,320,173→ 0 total
Conversion
aTYR PHARMA INC$ATYR
Series C Redeemable Convertible Preferred Stock
2015-05-12−2,127,660→ 0 total
Conversion
aTYR PHARMA INC$ATYR
Series D Redeemable Convertible Preferred Stock
2015-05-12−1,536,787→ 0 total
Conversion
aTYR PHARMA INC$ATYR
Series A Redeemable Convertible Preferred Stock
2015-05-12−2,400,000→ 0 total
Conversion
aTYR PHARMA INC$ATYR
Series B Redeemable Convertible Preferred Stock
2015-05-12−3,600,000→ 0 total
Conversion
aTYR PHARMA INC$ATYR
Series E Redeemable Convertible Preferred Stock
2015-05-12−893,655→ 0 total
Exercise/Conversion
MOMENTA PHARMACEUTICALS INC
Common Stock
2015-05-12$10.44/sh+38,400→ 107,523 total
Sale
MOMENTA PHARMACEUTICALS INC
Common Stock
2015-05-12$19.96/sh−38,400→ 69,123 total
Exercise/Conversion
MOMENTA PHARMACEUTICALS INC
Stock Option (Right to Buy)
2015-05-12−38,400→ 0 total
Conversion
aTYR PHARMA INC$ATYR
Common Stock
2015-05-12+92,306→ 104,878 total
Conversion
aTYR PHARMA INC$ATYR
Common Stock
2015-05-12+1,758,158→ 1,758,158 total
Purchase
Verastem, Inc.$VSTM
Common Stock
2013-06-12$9.60/sh+23,171→ 2,329,121 total
Award
MOMENTA PHARMACEUTICALS INC
Stock Option (Right to Buy)
2013-06-11+17,750→ 179,250 total
Purchase
Verastem, Inc.$VSTM
Common Stock
2013-06-11$9.22/sh+25,000→ 2,305,950 total
Award
ALNYLAM PHARMACEUTICALS, INC.$ALNY
Stock Option (Right to Buy)
2013-06-06+15,000→ 15,000 total
Award
Verastem, Inc.$VSTM
Stock Option (Right to Buy)
2013-06-04+12,500→ 12,500 total
Purchase
Verastem, Inc.$VSTM
Common Stock
2013-05-13$9.73/sh+25,000→ 2,280,950 total
Purchase
Verastem, Inc.$VSTM
Common Stock
2013-05-01$9.66/sh+10,000→ 2,255,950 total
Purchase
Verastem, Inc.$VSTM
Common Stock
2013-04-17$9.50/sh+5,631→ 2,245,950 total
Purchase
Verastem, Inc.$VSTM
Common Stock
2012-12-18$7.87/sh+6,193→ 2,240,319 total
Award
ALNYLAM PHARMACEUTICALS, INC.$ALNY
Stock Option (Right to Buy)
2012-06-21+15,000→ 15,000 total

CLARKE JOHN K

Recent Transactions

Companies

Recent Filings

Address